- Home
- BCRX vs ACHC Comparison
BCRX vs ACHC Comparison
Compare BCRX & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- ACHC
- Stock Information
- Founded
- BCRX 1986
- ACHC 2005
- Country
- BCRX United States
- ACHC United States
- Employees
- BCRX N/A
- ACHC N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- ACHC Medical Specialities
- Sector
- BCRX Health Care
- ACHC Health Care
- Exchange
- BCRX Nasdaq
- ACHC Nasdaq
- Market Cap
- BCRX 1.8B
- ACHC 1.7B
- IPO Year
- BCRX 1994
- ACHC N/A
- Fundamental
- Price
- BCRX $8.27
- ACHC $23.72
- Analyst Decision
- BCRX Strong Buy
- ACHC Strong Buy
- Analyst Count
- BCRX 10
- ACHC 10
- Target Price
- BCRX $16.70
- ACHC $42.85
- AVG Volume (30 Days)
- BCRX 2.3M
- ACHC 2.4M
- Earning Date
- BCRX 11-03-2025
- ACHC 10-29-2025
- Dividend Yield
- BCRX N/A
- ACHC N/A
- EPS Growth
- BCRX N/A
- ACHC N/A
- EPS
- BCRX N/A
- ACHC 1.52
- Revenue
- BCRX $557,506,000.00
- ACHC $3,229,609,000.00
- Revenue This Year
- BCRX $41.37
- ACHC $7.48
- Revenue Next Year
- BCRX $7.56
- ACHC $7.40
- P/E Ratio
- BCRX N/A
- ACHC $15.58
- Revenue Growth
- BCRX 45.85
- ACHC 5.64
- 52 Week Low
- BCRX $6.02
- ACHC $17.13
- 52 Week High
- BCRX $11.31
- ACHC $79.83
- Technical
- Relative Strength Index (RSI)
- BCRX 43.55
- ACHC 63.11
- Support Level
- BCRX $8.02
- ACHC $22.88
- Resistance Level
- BCRX $8.68
- ACHC $22.35
- Average True Range (ATR)
- BCRX 0.22
- ACHC 0.79
- MACD
- BCRX 0.01
- ACHC 0.30
- Stochastic Oscillator
- BCRX 37.88
- ACHC 79.17
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.